Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy
Xiaochen Qi, Quanlin Li, Xiangyu Che, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma
Haozhen Lv, Xiao Liu, Xuanhao Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 183
The crosstalk between copper-induced oxidative stress and cuproptosis: a novel potential anticancer paradigm
Thi Thuy Tien Vo, Tzu‐Yu Peng, Thi Hong Nguyen, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
Rui Qin, Feng‐Ming You, Qian Zhao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 61
Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Melanoma biology and treatment: a review of novel regulated cell death-based approaches
Ming-yun Hsieh, Sheng‐Kai Hsu, Tzu‐Yu Liu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma
Duguang Li, Zhaoqi Shi, Xiaolong Liu, et al.
Hepatology International (2023) Vol. 17, Iss. 1, pp. 112-130
Closed Access | Times Cited: 22
The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma
Huiyang Yuan, Xin Qin, Jing Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy
Yonghao Sun, Zuoxing Xue, Tao Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
Cuproptosis in lung cancer: mechanisms and therapeutic potential
Qixuan Li, Tianyi Wang, Youlang Zhou, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 6, pp. 1487-1499
Closed Access | Times Cited: 16
Deciphering the immunological and prognostic features of hepatocellular carcinoma through ADP-ribosylation–related genes analysis and identify potential therapeutic target ARFIP2
Fenfen Jiang, Xu Yan, Zhuang De Jiang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111073-111073
Open Access | Times Cited: 4
Redox chemical delivery system: an innovative strategy for the treatment of neurodegenerative diseases
Jeevan Lal Prajapati, Yogita Dhurandhar, Arun K. Singh, et al.
Expert Opinion on Drug Delivery (2025)
Closed Access
Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer
Li Liu, Qing Wang, Jiayun Zhou, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
Xiaojing Yang, Xing Wang, Xinti Sun, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
Polyphenol Mediated Suppression of Hepatocellular Carcinoma (HepG2) Cell Proliferation by Clerodendrum infortunatum L. Root
Imali Ranatunge, Preethi Soysa
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 1, pp. 351-363
Open Access | Times Cited: 2
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma
Yu Tanaka, Tokiko Nakai, Ayako Suzuki, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2205-2215
Open Access | Times Cited: 6
Molecular characteristics and prognostic significances of lysosomal-dependent cell death in kidney renal clear cell carcinoma
Shunliang He, Jiaao Sun, Hewen Guan, et al.
Aging (2024)
Open Access | Times Cited: 2
Exploring diverse programmed cell-death patterns to develop a novel gene signature for predicting the prognosis of lung adenocarcinoma patients
Zhanming Ma, Yue Wang, Yaxin Yu, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 2, pp. 911-923
Open Access | Times Cited: 1
Zosterabisphenone B, a new diarylheptanoid heterodimer from the seagrass Zostera marina, induces apoptosis cell death in colon cancer cells and reduces tumour growth in mice
Nunzio Antonio Cacciola, Paola De Cicco, Rebecca Amico, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 4168-4176
Closed Access | Times Cited: 1
Cuproptosis engineered nanomaterials: The silent warrior against cancer
Tenzin Sonam Dongsar, Tenzin Tsering Dongsar, Nazim Nasir, et al.
Applied Materials Today (2024) Vol. 39, pp. 102305-102305
Closed Access | Times Cited: 1
Design, synthesis and antitumor activity of 3,4,5-Trisubstituted Isoxazoles
Kanghui Duan, Fuxing Tan, Hongming Xie, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100203-100203
Open Access | Times Cited: 1
Targeting the lung tumor stroma: harnessing nanoparticles for effective therapeutic interventions
Shushu Zhang, Hui Wang
Journal of drug targeting (2024) Vol. 33, Iss. 1, pp. 60-86
Closed Access | Times Cited: 1
Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer
Jili Zhang, Shaoqin Jiang, Di Gu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Marine natural product lepadin A as a novel inducer of immunogenic cell death via CD91-dependent pathway
Dalila Carbone, Carmela Gallo, Genoveffa Nuzzo, et al.
Natural Products and Bioprospecting (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
A novel cuproptosis pattern and tumor immune microenvironment characterization in urothelial carcinoma of the bladder
Huan Feng, Zhiyao Deng, Yibao Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy
Carrie E. Andrews, Jenny Zilberberg, Raul Perez-Olle, et al.
Journal of Neuro-Oncology (2023) Vol. 165, Iss. 3, pp. 389-398
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top